Mackenzie Financial Corp Increases Stock Position in Maximus, Inc. (NYSE:MMS)

Mackenzie Financial Corp grew its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 2.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,782,150 shares of the health services provider's stock after buying an additional 55,583 shares during the quarter. Mackenzie Financial Corp owned 4.92% of Maximus worth $207,687,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. PharVision Advisers LLC purchased a new position in shares of Maximus during the 4th quarter valued at $252,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Maximus by 35.4% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 168,936 shares of the health services provider's stock valued at $12,611,000 after acquiring an additional 44,182 shares during the period. Voloridge Investment Management LLC lifted its holdings in Maximus by 306.8% during the fourth quarter. Voloridge Investment Management LLC now owns 376,055 shares of the health services provider's stock valued at $28,073,000 after purchasing an additional 283,608 shares during the last quarter. Vident Advisory LLC bought a new position in Maximus during the fourth quarter worth about $1,075,000. Finally, Squarepoint Ops LLC bought a new position in Maximus during the fourth quarter worth about $22,661,000. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Separately, Wall Street Zen cut shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.

Maximus Stock Performance

Shares of Maximus stock traded up $2.21 during trading hours on Tuesday, reaching $74.61. The company had a trading volume of 395,575 shares, compared to its average volume of 561,827. The firm has a market cap of $4.20 billion, a PE ratio of 16.05 and a beta of 0.61. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The business has a fifty day simple moving average of $69.59 and a 200 day simple moving average of $71.93.

Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The business had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same period in the prior year, the company posted $1.57 EPS. The business's revenue for the quarter was up 1.0% compared to the same quarter last year. On average, analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.61%. The ex-dividend date is Thursday, May 15th. Maximus's payout ratio is 23.86%.

Insider Transactions at Maximus

In related news, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.60% of the company's stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.